SMSabrina Meng

Sabrina Meng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sabrina Meng has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Objective dyspnea measurement in real time using a forehead wearable and artificial intelligence

    by Sabrina Meng, Alexandru Bogdan, Alireza Akhbardeh, Hersh Sagreiya

    Dyspnea is a complex symptom measured using subjective patient-reported ratings. Continuous, automated dyspnea measurements are needed, especially in critical care and trauma settings with impaired patient communication. We prospectively enrolled 54 pulmonary rehabilitation subjects. Participants completed two treadmill walking trials, during which dyspnea measurements were collected at one-minute intervals automatically using physiologic sensors and patient-reported ratings of perceived breathlessness and exertion (RPB and RPE). The sensor data were used to train machine learning models using either 19 or 7 features to generate an objective dyspnea score (ODS). Classification performance was assessed on a held-out test set, compared against patient-reported RPB and RPE. The model trained on 7 features performed best, resulting in a correlation between predicted and actual scores (percent accuracy) of 0.84 (78.7%) for RPE and 0.86 (83.6%) for RPB. Our system incorporating ODS accurately predicts patients' subjective dyspnea scores and is promising for automated, real-time dyspnea measurement.

  • Open Access

    Prediction of Chronic Obstructive Pulmonary Disease Using Machine Learning, Clinical Summary Notes, and Vital Signs: A Single-Center Retrospective Cohort Study in the United States

    by Sabrina Meng, Hersh Sagreiya, Negar Orangi-Fard

    Introduction: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality. Early identification and timely intervention for COPD exacerbations can reduce hospitalizations and complications, as well as improve patient outcomes. Methods: To develop and evaluate predictive models for COPD exacerbations using machine learning (ML), we performed a retrospective study using intensive care unit patient records. Records including 31,667 clinical notes and 10,489 vital signs were used to train and validate two machine learning models to predict COPD exacerbations in patients with known or suspected COPD. Predictive performance was evaluated for support vector machine, quadratic discriminant analysis, and adaptive boosting algorithms using area under the receiver operating characteristic curve (AUC). Results: The clinical note-based support vector machine model achieved an AUC of 0.81 and accuracy of 84.0% in predicting COPD exacerbations. Data from patient monitors and hospital information systems provided sufficient information for accurate prediction, demonstrating the utility of combining physiological signals with clinical text data. Discussion: Clinically available patient data and vital signs can effectively predict COPD exacerbations, potentially enabling earlier interventions, improved outcomes, and reduced healthcare burden. These findings suggest that integrating unstructured clinical notes with structured vital signs using ML frameworks may improve early detection of exacerbation risk, thus enabling appropriate patient counseling, triage, and treatment based on COPD severity.

  • Open Access

    Bidirectional Associations Between Seborrheic Dermatitis and Epithelial Barrier Diseases: A Retrospective Cohort Study

    by Sabrina Meng, Ronald Berna, Junko Takeshita, Ole Hoffstad, Daniel Shin, Nandita Mitra, David J. Margolis

    Background: Seborrheic dermatitis ( SD ) is a common skin disease characterized by epithelial barrier breakdown. The epithelial barrier theory ( EBT ) implicates epithelial barrier disruption in the development of epithelial barrier diseases ( EBDs ). We hypothesized that SD is associated with an increased risk of EBDs and investigated the bidirectional association between SD and EBDs . Methods: Retrospective cohort study of 5,083,689 patients using a large US administrative claims database from January 1, 2016, to June 30, 2022. The mean (standard deviation) follow‐up was 3.25 (1.75) years with a total follow‐up of over 16 million person‐years. The outcomes were a diagnosis of (i) SD after an EBD and (ii) EBD after SD, analyzed using a multivariable Cox proportional hazards model (hazard ratio [95% confidence interval]). Results: The risk of SD was increased after EBD diagnosis for multiple diseases, including atopic dermatitis [2.46 (2.40, 2.53)], alopecia areata [3.47 (3.24, 3.71)], contact dermatitis [1.92 (1.88, 1.96)], psoriasis [2.62 (2.54, 2.69)], rosacea [2.84 (2.78, 2.90)], hidradenitis suppurativa [1.79 (1.63, 1.97)], rhinosinusitis [1.34 (1.32, 1.35)], food allergy [1.47 (1.42, 1.54)], celiac disease [1.55 (1.43, 1.68)], ocular allergy [1.55 (1.49, 1.61)], and dry eye [1.54 (1.52, 1.56)]. The risk of EBD after SD diagnosis followed similar trends, with the largest effect estimates being psoriasis [3.52 (3.42, 3.61)], rosacea [2.85 (2.79, 2.92)], and alopecia areata [2.81 (2.61, 3.03)]. Conclusions: Our results support the EBT as a shared driver of EBD pathogenesis at not only local (e.g., skin) barriers but also at non‐local sites, including the respiratory, gastrointestinal, and ocular epithelial barriers.